TIDMBIOG 
 
The Biotech Growth Trust PLC ("the Company") 
 
Compliance with Market Abuse Regulation 
 
4 May 2021 
 
The Company confirms that: 
 
a)         all inside information which the Directors and Company may have had 
has been notified to a Regulated Information Service ("RIS"); 
 
b)         the Company's net asset value per share is calculated and announced 
through a RIS on a daily basis; 
 
c)         the Company has no reason to believe that there will be any material 
difference between the net asset value per share as at close of business on 
Wednesday 31 March 2021, which was announced on Thursday, 1 April 2021, and the 
financial information to be published in the announcement of its results for 
the year ended 31 March 2021. 
 
The Company is, therefore, not prohibited from dealing in its own securities 
during the closed period, as defined by the UK Market Abuse Regulation, which 
will end on the date of the publication of its results for the year ended 31 
March 2021, expected to be on or after Friday, 4 June 2021. 
 
                                    -ENDS- 
 
For further information please contact: 
 
Mark Pope      Frostrow Capital LLP - 020 3 008 4913 
 
 
 
END

(END) Dow Jones Newswires

May 04, 2021 06:03 ET (10:03 GMT)

Biotech Growth (LSE:BIOG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Biotech Growth Charts.
Biotech Growth (LSE:BIOG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Biotech Growth Charts.